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Background: More involvement of sub-Saharan African countries in biomedical studies, specifically in genetic
research, is needed to advance individualized medicine that will benefit non-European populations. Missing
infrastructure, cultural and religious beliefs as well as lack of understanding of research benefits can pose a
challenge to recruitment. Here we describe recruitment efforts for a large genetic study requiring three-generation
pedigrees within the Yoruba homelands of Nigeria. The aim of the study was to identify genes responsible for
keloids, a wound healing disorder. We also discuss ethical and logistical considerations that we encountered in
preparation for this research endeavor.
Methods: Protocols for this bi-national intercultural study were approved by the Institutional Review Board (IRB) in
the US and the ethics committees of the Nigerian institutions for consideration of cultural differences. Principles of
community based participatory research were employed throughout the recruitment process. Keloid patients
(patient advisors), community leaders, kings/chiefs and medical directors were engaged to assist the research teams
with recruitment strategies. Community meetings, church forums, and media outlets (study flyers, radio and TV
announcements) were utilized to promote the study in Nigeria. Recruitment of research participants was conducted
by trained staff from the local communities. Pedigree structures were re-analyzed on a regular basis as new family
members were recruited and recruitment challenges were documented.
Results: Total recruitment surpassed 4200 study participants over a 7-year period including 79 families with
complete three-generation pedigrees. In 9 families more than 20 family members participated, however, in 5 of
these families, we encountered issues with pedigree structure as members from different branches presented
inconsistent family histories. These issues were due to the traditional open family structure amongst the Yoruba
and by beliefs in voodoo or in juju. In addition, family members living in other parts of the country or abroad
complicated timely and complete family recruitment.
Conclusions: Organizational, logistics and ethics challenges can be overcome by additional administrative efforts,
good communication, community involvement and education of staff members. However, recruitment challenges
due to infrastructural shortcomings or cultural and religious beliefs can lead to significant delays, which may
negatively affect study time lines and expectations of funding agencies.
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While most research on common or rare disorders has
in the past been conducted in European and East Asian
populations, there is increasing interest in conducting
such studies in sub-Saharan African populations. There
is a growing recognition that health disparity research
will be improved by including populations with gene-
tically diverse background. This means we need to in-
clude more sub-Saharan Africans in genetic research for
common and rare-disorders, especially as this region is
known to harbor the greatest amount of genetic varia-
tion within our species [1].
Within the United States, minority recruitment for
genetic/family studies has been recognized as crucial to
understand genetic variation and to enable genera-
lization of research findings. Pharmacogenomic studies,
for example, investigate the efficacy of pharmacologic
agents in populations with certain genetic characteristics
[2-4]. Genetic research in African populations is needed
to study the genetic predisposition of Africans to certain
diseases. Currently there are projects under way to in-
vestigate proposed rheumatoid arthritis loci in African
populations [5], to investigate susceptibility of Nigerians
to risk loci for chronic kidney disease [6] or to study the
effect of certain promoter variants for modulation of
serologic autoimmunity to SLE [7].
The Yoruba ethnic group of Nigeria has been sampled
in previous genetic studies. The Yorubas were part of the
international HapMap studies that led to the sequencing
of the Human Genome [8] and to create a map of human
genome sequence variations [9]. Samples from the Yoruba
ethnic group were also included to collectively identify >3
million common DNA variants, primarily SNPs [10]. SNP
data and their linkage disequilibrium patterns provide
basic information for genome-wide association studies in
African or admixed populations [8,10-13].
However, to our knowledge there are no genetic stu-
dies that use the Nigerian or Yoruba population as their
primary target. Our study is in the process of identifying
the genetic basis for keloid formation, a wound healing
disorder, with the Yoruba ethnic group as the primary
target population.Figure 1 Patients with typical keloid scars on sternum, back and earloKeloids are scars that grow over the margin of the ori-
ginal injury to the dermis (Figure 1). This often disfi-
guring, painful, and stigmatizing scar can occur after a
minor cut or trauma to healthy skin. Keloids occur mostly
in dark pigmented populations [14,15] including the Yor-
uba people of Nigeria. There is no good and efficient treat-
ment for keloids [16,17]. It has been generally accepted
that there is a genetic basis for keloids [18-21]. However,
the mode of inheritance is still unsettled. Some studies
suggest that the keloid inheritance pattern is autosomal
dominant [21,22] while a study of 34 Yoruba family pe-
digrees (from Nigeria) supported autosomal recessive in-
heritance [23].
The Yoruba awareness of keloids predates the first publi-
cation on keloids in Western literature [24,25]. According
to Omo-Dare, Yorubas for long have referred to keloids in
their art and literature [26]. Indeed, one of the 140 chap-
ters in the Ifa literary corpus is dedicated to keloids; with
artifacts/sculptures and folklore reflecting keloids. The
Yorubas, with their local customs of facial markings and
earlobe perforations, recorded their familiarity with keloids
10 centuries before Alibert and Retz [27].
For modern-day genetic research, it is often necessary to
recruit thousands of participants, especially for association
studies. In the instance of case-control studies, only a sin-
gle affected participant or a single unaffected control indi-
vidual per family is recruited. Other strategies involve the
recruitment of trios (father, mother, and affected offspring)
or sib-pairs. Recruitment for those studies may be rela-
tively straight-forward, although not trivial. For linkage
studies, however, large families must be identified where
the disorder of interest is transmitted. Challenges arise
when many informative family members need to be re-
cruited to give enough power to a pedigree for independ-
ent identification of a disease gene locus. Developing
strategies to present the research to potential study partic-
ipants in a manner that enhances voluntary participation
of family members from all generations becomes essential,
and can be a challenge.
Suggestions to enhance recruitment for genetic/family
studies with emphasis on minority recruitment in the
US or recruitment in Africa have been addressed in thebe.
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strategies or recruitment experience for genetic/family
studies in the Yoruba population is limited. This article
documents our recruitment experience for a genetic
linkage study in the Yoruba population in Nigeria and
describes the challenges we faced as well as methods
used to reduce these challenges.
Setting: Nigeria
Nigeria is a country in West Africa with an estimated
population of 170,000,000 (census 2010), which is com-
posed of 250 ethnic groups including Hausa and Fulani
(29%), Yoruba (21%), Ibo (18%), Ijaw (10%), Kanuri (4%),
Ibibio (3.5%), and Tiv (2.5%). Nigeria was a port for the
slave trade and obtained its independence in 1960 from
Great Britain. The official language is English but the
three major local languages are Hausa, Yoruba, and Ibo,
along with more than 200 dialects. The Yoruba home-
lands are in the western part of Nigeria, the Igbo reside
in the east, while the Hausa and Fulani live in the north.
Lessons learned
This study was carried out with careful consideration of
cultural issues in the host country. We followed re-
commendations to enhance recruitment in such low
resource-limited settings [29,31]. Here we share our ex-
perience on several issues that impacted our recruitment
for consideration in future studies.
Methods
Recruitment sites
Participant recruitment was carried out in Ibadan (Oyo
State) and Osogbo (Osun State) as well as in surroun-
ding towns and villages. Ibadan is the capital of Oyo
state with a population of 1.3 million, the third-largest
metropolitan area in Nigeria after Lagos and Kano.
Ibadan is located in south western Nigeria with the princi-
pal inhabitants being ethnic Yoruba. There are several
smaller towns and villages around Ibadan where recruit-
ment of study participants took place including Ogbomoso,
Egbeda, Oyo, Iseyin and others. Osogbo, the second re-
cruitment site for this study is the capital of Osun State
with a population of approximately 160,000 (by 2006
census). Most of the inhabitants are Yorubas. Recruitment
around Osogbo extended to surrounding towns, including
Ile-Ife, Modakeke, Ikirun, Ilesa, Ede, and Ikire, among
others. The population structure and culture in Oyo and
Osun States are very similar.
Study preparations and interaction between US and
Nigerian research groups
Potential study sites and plastic surgeons who were in-
terested in a genetic study were identified through per-
sonal contact with a health care professional in Ibadan.The US researchers worked with the local researchers
from the inception of this project. Ethics approval from an
IRB in the US and ethics committees in Nigeria was
obtained for the initial pilot study prior to the US re-
searchers’ first visit to Nigeria. During the first visit to
Osogbo, which was paid for by institutional funds and by
the University of Connecticut Health Center (UCHC)
General Clinical Research Center (GCRC), the US scien-
tists met with Nigerian plastic and general surgeons and
chief medical directors of different hospitals as well as
with provosts of colleges of health sciences to describe the
goals and objectives of the research project. Discussions
followed on the prevalence of keloids in their clinics and
the surrounding communities, as well as on how to en-
gage the community leaders and how to dispel fears and
concerns related to research amongst the keloid patient
population. Plans were developed on how to address cul-
tural beliefs, and which methods would be most appro-
priate to promote the research study. Also discussed was
the feasibility of hiring staff through local hospitals, re-
search and ethics training for staff, plans for transporting
samples from surrounding towns, data collection and the
transfer of samples to the US. Additional activities in-
cluded FWA registration of the Nigerian institution in
Osogbo and human subjects training (CITI) for those in-
vestigators who did not already have that certification. As
a team, we outlined a feasible roadmap for the pilot study
with the goal of obtaining NIH funding (R01) for large-
scale recruitment.
Communication between the Nigerian teams and the re-
search group from the US involved emails and telephone
contacts between regular visits to Nigeria. Consenting and
privacy (HIPAA) documents were reconciled regularly to
be acceptable to the ethics committees and IRB on both
sides. As NIH funding was obtained, subcontracts bet-
ween institutions were developed and an additional re-
cruitment site in Ibadan was instituted. Investigators
reviewed recruitment processes collaboratively, planned
and implemented recruitment in surrounding towns and
villages and updated staff training to the Nigerian research
teams during regular visits throughout the recruitment
period. While in Nigeria, the US team took part in recruit-
ment efforts, meetings with community leaders, educa-
tional forums and media presentations.
Study design
The primary goal of this cohort study was to recruit
families where keloids are inherited in an effort to iden-
tify the genetic basis for keloid scar formation. The
focus of recruitment was on large multi-generation fa-
milies. Keloids were assumed inherited when several
members of a family were affected. Probands who did
not report any additional affected family member were
classified as sporadic or singular cases. Data discussed
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2013.
Ethics approval was obtained from the Institutional Re-
view Board of the University of Connecticut (IRB#03-007)
and the ethics committees of the Ladoke Akintola Uni-
versity of Technology (LAUTECH), College of Health
Sciences, Osogbo and the College of Medicine, University
of Ibadan/University College Hospital (UI/UCH), Ibadan.
All oversight committees had obtained Federal Wide
Assurance (FWA). Recruitment of study participants was
performed by trained recruitment teams under the
supervision of plastic surgeons at LAUTECH and the (UI/
UCH). Recruitment was supported by NIH-funded sub-
contracts with both institutions. Each recruitment team
consisted of trained nurses, research assistants and two
surgeons to direct the recruitment efforts as co-investi-
gators and to diagnose participants. Training of staff
included human subjects training as well as training to
differentiate between keloids and other wound healing dis-
orders (e.g., hypertrophic scars). All team members and
surgeons were Yorubas who lived in the community and
were employed at the respective teaching hospitals. The
US research team included a Yoruba nurse research asso-
ciate who was the professional and cultural liaison be-
tween the research teams from the US and Nigeria and the
Nigerian community. The American research team tra-
velled to Nigeria 1-2 times a year to provide support and
technical assistance to the Nigerian teams.
Recruitment strategies
Probands were recruited either in the hospitals at
LAUTECH in Osogbo and UCH in Ibadan or in the com-
munity. Outside the hospital settings, participants were re-
cruited in private and public clinics, private homes or by
invitation in churches and mosques.
Patient advisors
We utilized a modified community-based participatory
research approach to engage keloid patients and the
community at large. A number of keloid patients who
were recruited in the early phases of the study served as
patient advisors. The research teams educated them
about the goals of the project and the involvement of re-
search participants. Patient advisors assisted by passing
information about the project to individuals with keloids
in their communities, and instructed them to contact
the recruitment team if they were interested in par-
ticipating. While patient advisors were generally able to
answer many questions of participants, they did not par-
ticipate in the actual recruitment.
Community leaders
To initiate recruitment in a new town, the groups visited
the king or his chiefs and ward leaders, who holdimportant leadership roles within the community, to
explain the purpose of the research and the need for
cooperation of the population. At those meetings the
research team could answer questions from the leaders
and/or the community. Posters and handbills (flyers)
were distributed during the visits.
Health directors
Medical and nursing directors of local health centers
and private hospitals were approached with the request
to identify study participants which would then be re-
cruited by the Nigerian research staff. Posters and hand-
bills with pictures of keloids were made available in the
clinics to introduce the research project to patients.
Churches/mosques
We solicited the assistance of pastors and imams to
share the research study with their congregations. The
religious leaders gave us permission to explain the study
during a special announcement period. Research teams
stayed after the service to answer questions and set up
appointments for recruitment.
Advertisement
Handbills and posters were distributed in the communi-
ties, specifically in market places, private and public
health clinics, schools, churches, pharmacies and clinical
laboratories. The posters and handbills in English and
Yoruba language contained information about the study,
contact information and stipend.
Media
The research team made radio and TV presentations in
English and Yoruba language describing the purpose of
the study, eligibility criteria and contact information. In
addition, radio and television announcements were run
to advertise the study and to dispel some myths about
keloids.
Affected/enrolled participants with keloids
Often times, enrolled participants were asked to spread
word about upcoming recruitment visits in their com-
munity. As a result, additional keloid patients usually
came to the recruitment site to join in the study.
Participant recruitment
Recruitment and enrollment of participants took place
in the plastic surgery clinics in Ibadan or Osogbo hospi-
tals and in the community (participant’s home, work
place and other chosen site). Diagnosis of keloids was
confirmed by the clinicians heading the recruitment
teams.
The consenting process involved explaining the study
to potential participants. Prospective participants were
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to read or have them read to them.
Participants were given sufficient time for review and to
ask questions. They had the option to participate the same
day or at a later day if they would like to discuss further
with their family. Usually, married women liked to discuss
with their husbands before agreeing to participate. After
consent was obtained, the recruiter and the research
participant filled a questionnaire to document the parti-
cipant’s personal information, keloid history and past
medical history. Minors between ages 7 and 12 signed
assent forms and in addition, the recruiter obtained paren-
tal consent. Older minors signed the consent forms to-
gether with a parent. Keloid site(s) and sizes of lesions
were documented in a questionnaire (body map) and pho-
tographs of keloids and other scars were taken. Partici-
pants consented to have images of their keloids (Figure 1)
used in scientific articles. Research assistants constructed
pedigrees when probands reported other affected family
members.
Probands were asked to inform other family members
about the study so they could contact the research team
if interested. Family recruitment often took place in their
homes which required the research team to travel to
their towns or villages. We also recruited large cohorts
of patients with keloids without family history (or with
no other family members available for the study) and
control individuals without keloids. Eligibility criteria for
participation as unaffected control individuals were the
absence of keloids or suspicious scars and that no mem-
ber of their families had keloids, suspicious scars or skin
diseases. Only one control individual per unaffected
family was recruited. Recruitment settings for controls
were the same as for the keloid case recruitment.
Contact information of all participants was collected in
case clarifications were required during the course of the
study. Participants were given a sum of approximately
$10 (USD) (Naira 1,500.00) as compensation for trans-
portation and inconvenience. Venous blood samples
(Vacutainer, Becton Dickinson, USA) or saliva samples
(OraGene saliva kits; DNA Genotek, Ontario, Canada)
were collected and transported to the US for processing
at the University of Connecticut Health Center. Each
participant was given a unique identification number.Analysis
Pedigrees were entered into Progeny pedigree drawing
software (Progeny Software, LLC, Indianapolis, IN,
USA) and were updated whenever new information
about a family was obtained. Statistical analyses were
performed in Excel and SPSS. Challenges observed in
the process of recruitment and issues that could affect
genotype analysis were documented.Results
Administrative challenges
Before the actual study could commence a number of ad-
ministrative steps were necessary to establish agreements
between institutions, to train research staff and to ensure
that ethics approvals were in place so that the project
would accord with the latest standards of human subject
protection.
The first recruitment site for our study, LAUTECH
Teaching Hospital, Osogbo, Nigeria, was founded in 2000
with limited experience in collaborative research with
foreign institutions. The first challenge for establishing a
research relationship between an established institution in
the United States and a new Nigerian teaching hospital
was in regards to human subject protection and finance
administration (see the List of administrative challenges
section). First the Nigerian site had to register with the
United States Department of Health and Human Services
to receive a Federal Wide Assurance (FWA) number.
Principal Investigators needed to complete human sub-
jects training with the Collaborative Institutional Training
Initiative (CITI) before they could be added to any re-
search protocol approved by the University of Connecticut
Health Center (UCHC) Institutional Review Board (IRB).
Consenting documents had to be crafted to suffice all hu-
man subjects protection elements and oversight require-
ments for UCHC protocols. Problems for the Nigerian
ethics committee arose when paragraphs were included
that are only relevant to the US but may be confusing to
participants in Nigeria. Examples of where study partici-
pants can get confused are references to:
a) Health Insurance Privacy Portability Act (HIPAA)
and health insurance providers, because health
insurance is unavailable to most Nigerians;
b) Requirements of a specific US State, which do not
apply to Nigeria;
c) US oversight committees that may gain access to
consenting materials (Protected Health Information
(PHI) in case of project audits.
Consents and HIPAA forms need to be carefully crafted
to consider the environment and culture of research
participants [31]. Recruitment materials needed to be ap-
proved by ethics committees/IRBs of both institutions.
Training of all research staff in ethics and research com-
pliance was needed before any approval could occur.
Training was performed by the US staff during extended
visits.
List of administrative challenges
 Inexperience of investigators and institutions in
international collaborations
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feasibility of study to funding agencies
 Registration of Nigerian recruitment sites for
Federal Wide Assurance (FWA)
 Adapting wording of consent/HIPAA forms to local
requirements
 Reconciling IRB requirements of US and Nigerian
institutions
 Human subjects training of new recruitment teams
 Implementation of subcontracts with different
expectations of financial administrations
 Maintaining ongoing communication between teams
to optimize recruitment and for trouble shooting
 Funds transfer due to differences in banking systems
Significant start-up funds were needed to initiate this
collaboration as funding agencies (e.g., NIH) will not
allow spending funds abroad until all compliance issues
are fulfilled and the foreign site is registered with the
funding agency. However, in order to start such a ge-
netic collaboration from scratch, travel costs, resources
for salaries in the host country as well as computers,
internet connection, cameras for documentation, re-
cruitment documents and operating funds had to be
funded in advance. Most institutions in low resource
countries cannot afford to finance salary expenses up-
front and be reimbursed later. Whenever banking sys-
tems are different, even the transfer of funds in itself
can pose an administrative challenge. Since Principal
Investigators at UCHC and LAUTECH had no prior
experience with the administrative and regulatory chal-
lenges of such a collaborative project and because such
a large international genetic study was new to adminis-
trations at both sides, our project suffered significant
delays.
The University of Ibadan, which was later added as a
second study site, had experience with international
collaborations as it had participated in previous re-
search activities including the HapMap project. As a
result of the experience gained with establishing the
first recruitment site at Osogbo, it was easier, although
not trivial, to add the University of Ibadan as the
second recruitment site.Recruitment challenges
There were several other challenges to successful re-
cruitment (see List of recruitment challenges section).
In most families there were some members who lived
far away, often located throughout Nigeria and even
abroad. Those who lived within the country but in other
states did not return to their home towns every year,
which prevented timely and complete recruitment of
many large families.List of recruitment challenges
 Obtaining referrals from clinics and community
centers without payment
 Unreliable transportation system and road
infrastructure
 Participants are less motivated to participate in
research without direct (health) benefits
 Participants reside in remote locations
 Participants lack funds to maintain mobile phones
 Participants do not show for appointments
 Difficulty to understand research project and
purpose
 Inaccuracies in family and clinical histories
 Lack of birth records for older adults
 Open family system which does not distinguish
between biological siblings and adopted or socially
related siblings
 Polygamy with families living far apart
 Hesitation to donate sample because of beliefs in
“voodoo” and “juju”
 Paternity issues
Furthermore, even though most people had mobile
phones, communication was problematic at times as most
probands did not have contact to all of the family mem-
bers. Frequently, the research group had to travel long dis-
tances for recruitment or to confirm pedigree structures,
especially in polygamous pedigrees where members from
one branch of the family had insufficient knowledge of
other parts of the family. On the other hand, we found
that children from one wife sometimes lived with families
of other wives and were fully accepted as children of the
family. Information about “brothers” or “sisters” had to be
confirmed by several sources since in many cases, families
did not distinguish between “sibling” or “half-sibling”.
Also, in this open family system, other relatives living with
families were often reported as immediate family mem-
bers and were therefore wrongly recruited.
For travel within the state, the recruitment teams had to
rely on public transportation. Public transportation was
plagued by unreliable connections; hence it was frequently
time consuming to commute to recruitment sites. Poor
road conditions made travel even more challenging, thus
reducing staff time for actual recruitment. Many of the
participants (older generations) did not have formal edu-
cation and found it difficult to understand the research
concept with no immediate benefit for their keloids, which
they often viewed as a stigmatizing condition. They were
more interested in a study that treats or cures keloids and
not particularly eager to participate in a study that will
take years before yielding meaningful results. Some indi-
viduals only wanted to participate if they could receive
free treatment.
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Osogbo or in neighboring towns through local hospitals,
community clinics and private clinics. This approach
often failed as clinicians, especially in private clinics,
were reluctant or not willing to inform keloid patients
about the study for fear that patients could be diverted
from them. Some health care providers (including some
hospital staff at host institutions) expected payment for
patient referrals to the study, commonly referred to as
“head money”. We considered payments for referrals as
unethical.
To reimburse any clinic for actual time and efforts
spent on recruitment, we would have needed a formal
contractual agreement. Establishing a formal contractual
agreement would have been a major administrative ef-
fort, necessitating involvement of the funding agency
and institutions managing the funds.
Accurate pedigrees and clinical histories were some-
times difficult to obtain for several reasons. Some partic-
ipants, especially those without formal education, had
no records of their birth dates and hence were guessing
their age, which was at times far off when we compared
the parental age to that of the children, who did have
birth certificates and some level of education. This prob-
lem was more common with women who did not attend
school and had no need to obtain official birth records.
We were therefore aware that we may have received in-
correct information regarding age or relationships des-
pite direct questions.
In some instances, we found discrepancies with geno-
typing results and had to re-visit families for clarifica-
tion. We had to exclude several individuals in key
families for our linkage study because participants could
no longer be reached or discrepancies could not be fully
resolved. Other issues included friends posing as family
members, or that individuals were addressed by different
names by different members of the family, which is not
uncommon in the Yoruba culture. These cultural idio-
syncrasies made it necessary to re-evaluate pedigrees
whenever new participants were recruited. For some
families it took 5 years to recruit all informative family
members who were interested in participating.
There were circumstances where remuneration be-
came a major factor for recruitment. While most study
participants were happy with the amount of compensa-
tion, some participants tried to negotiate for higher
compensation. Some individuals believed they should be
paid more because they had more keloids or because
they had a longer way to travel to a study site. Others
wanted extra payment before they would introduce the
research team to other family members. Recruitment
teams sometimes had to provide prepaid phone cards to
probands who were unable to call other family members
because of their financial situation. Occasionally, therewere extended delays in communication when family
members could not be reached because they lacked
funds to purchase phone cards. Some private clinics or
probands indicated that they were willing to work with
the research team if we let them distribute the study sti-
pend to referred participants. This would have allowed
them to split the remuneration after subject enrollment.
The study also faced challenges from religious beliefs
and cultural practices. The Yorubas have strong beliefs
in voodoo or juju, which vary within religious groups.
Some were convinced that their saliva and/or blood
would be used for evil rituals. As a result, families with-
drew from the study and the recruitment teams had to
destroy some samples that were already collected.
We strongly believe that deeply ingrained cultural be-
liefs also played a role when research teams had difficulties
to re-contact study participants. In such circumstances,
participants would find excuses or make appointments
with the recruiters and not show up rather than frankly
telling the research team that they were afraid of voodoo
or juju or do not wish to participate for other reasons.
This led to further delays in the recruitment progress and
sometimes was a dead end for the recruitment of a family
that would have been informative for the genetic study.
During sample analysis, we discovered inconsistencies
with paternity and false allocations of children from dif-
ferent wives. We also encountered friends or distant rel-
atives posing as close family members in at least 5 out of
more than 100 families. Recruitment in 3 large families
from the Osogbo group and 10 families from the Ibadan
group were delayed significantly because family mem-
bers relocated to different parts of Nigeria or to foreign
countries. Three Osogbo-based families withdrew from
the study or could not be recontacted for unknown rea-
sons while 9 families withdrew or could not be re-
contacted by the Ibadan recruitment center. The fear of
voodoo or juju prohibited the recruitment of a larger
number of family members in three families in Osogbo
while 5 individuals raised the issue of juju among pro-
spective participants in Ibadan. Most other family mem-
bers could usually be recruited.
Total recruitment exceeded 4200 study participants over
a 7-year period (Table 1). Sample collection in a number
of families was incomplete for various reasons, either be-
cause family members refused to participate for fear of
rituals or for unknown reasons or because of family mem-
bers living in other parts of the country. Participants who
had no family history or where no other family member
was available for recruitment were included in a case co-
hort for a future genome wide association study (GWAS).
We were able to recruit approximately 1,900 individuals
with keloids during the recruitment period. In preparation
for a GWAS, we also recruited more than 2,000 un-
affected control individuals. Our initial goal, however, was
Table 1 Summary of families recruited
Summary Number
Total numbers of samples collected 4200
Total number of families (pedigrees) where recruitment
took place
103
Total number of participants affected by keloids in all families 550
Number of affected keloid participants recruited from families 321
Total number of families with complete three generation
pedigrees
79
Number of families with greater than 20 participants 9
Number of families with greater than 10 participants 27
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susceptibility. We identified and recruited from more than
100 families with more than 550 participants. For 79
families, we were able to establish complete 3-generation
pedigrees. Of those families, only 27 had more than 10
participating family members and 9 had more than 20
members participating in the study.
Discussion
Scientific literature offers several recommendations on
ethical, legal and cultural considerations for research in
low resource settings and for recruitment of minority
populations. Experiences with community engagement
and informed consent for genetic studies in Africans
[28] and for obtaining DNA samples from four popula-
tions including the Yorubas from Ibadan (Nigeria) have
also been reported [29]. However, there is no report on
issues that should be considered when recruiting entire
families in rural and urban settings with genetic research
as the main goal.
Successful recruitment of diverse populations such as
the Yorubas for genetic studies is important for ad-
vancement in biomedical research. The Yoruba ethnic
group was chosen for this linkage analysis approach be-
cause we were expecting that large families with ke-
loids could be recruited. Due to the expected locus
heterogeneity for causative variants leading to keloids
[32-34], recruitment from the Yoruba population
seemed ideal for finding significant linkage because of
relatively low admixture [35,36] compared to many
other populations.
To attain acceptance of a genetic study within multiple
generations of a family, it is important to appreciate social,
religious, and cultural beliefs that may impact participa-
tion. The Yoruba ethnic group that occupies mostly the
western part of Nigeria highly values their cultural prac-
tices and religious beliefs. Although most Yorubas are
Christians or Muslims, they retain their practice of wor-
shiping different gods such as Sango (god of thunder),
Obatala also known as Orisa-nla (the shaper, former,
maker), Yemoja (god of the river) and Ogun (god of iron).All these beliefs create perceptions about the possible
causes for a disease and often determine the approach to
treatment. Traditional healers still have high influence on
people’s decisions. Part of their health beliefs is that
illnesses may originate from one or a combination of
three forces; the magical practices (witches or sor-
cerers), natural events (environmental, hereditary) and
supernatural occurrence (destiny or the individual’s
double spirits) [37-39]. It has also been documented that
many Nigerians approach treatment of diseases by utili-
zing Western medicine in combination with treatments
offered by traditional healers and “spiritual” centers [37].
For example, one study reported that some Yorubas
identified environmental factors such as diet and use of
unorthodox traditional herbs as the cause for cancer
[38]. The interest in experimenting with different treat-
ments could explain why some of the participants in our
keloid study reported treatment of their keloids with a
combination of traditional herbs and Western medicine
and why they were willing to contribute to science to
find better treatment or cure. However, stigmatizing
and/or painful diseases such as cleft lip and palate, can-
cer or keloids are by some perceived to be in part due to
a “punishment” for evil deeds or result from retaliation
by a jealous foe [37,38,40]. As a result, many Nigerians
are weary of participating in studies that have the po-
tential of “affecting” them or other family members,
especially if they donate blood, saliva or hair samples.
Recruitment was also affected by challenges that had
already been described in other cultural environments
[30,41]. Such issues included economic factors, lack of
trust, different cultural background of researchers and
study participants, or issues with time and transporta-
tion needed to reach remotely located family members.
Meeting regulatory and administrative requirements
(IRB, ethics committees and FWA) as well as staff trai-
ning was less of a problem compared to recruitment chal-
lenges. Research staff took the Collaborative Institutional
Training Initiative (CITI) training for good clinical prac-
tice before they engaged in recruitment. An online educa-
tion module for ethics training on research based on the
Nigerian Code for Health Research Ethics has recently
been developed and validated. Future studies will require
research staff to take this module that encompasses the
Nigerian cultural and social principles [42].
Our experience with this study confirmed the need to
allocate extra time for all stages of the study. Extra time
was needed to educate the public and prospective research
participants about the study and to make up for delays
due to travel logistics when recruiting relatives residing
outside a proband’s home town or when family members
were not available for recruitment in a timely manner.
Additional challenges arose during the rainy season when
treacherous road conditions led to extended delays.
Olaitan et al. BMC Medical Ethics 2014, 15:65 Page 9 of 11
http://www.biomedcentral.com/1472-6939/15/65Unreliable public transport slowed down recruitment
throughout the study period. While purchasing a car dedi-
cated to the study might have been the most economical
way to travel to recruitment sites, administrative barriers
and uncertain liability issues prevented us from doing so.
Working with an institution with established research
infrastructure versus a site without any research infra-
structure or experience with foreign collaboration should
be taken into consideration when planning a study as this
will likely impact timely study initiation, staff recruitment,
and research coordination. There is recognition that
capacity building in African countries must be addressed
for successful integration of human genetic studies [43].
Nigerians and specifically the Yorubas are generally not
research-naïve. Participation of Yorubas or any under-
served population in genetic studies can be enhanced by
community involvement from inception of the study as
well as by regular feedback [30], especially when the
study design involves participation of family members
from several generations. Our study plan included the
assistance from probands or other individuals with
keloids and contact with community leaders, kings or
chiefs where applicable. Interaction with members of the
oldest generation or children of old family members
may be difficult when the culture of scientists and re-
cruiters is different from that of the participants. To ad-
dress these and other issues, our study involved research
staff from the local community who were born and
raised in the Yoruba culture. Visits to kings, chiefs,
churches and mosques were useful to convince the com-
munity that blood and saliva samples would not be used
for voodoo or juju. It was important and reassuring to
be accompanied by research participants from their
community at such meetings to demonstrate that nothing
bad had happened to them since recruitment. It was also
important to ensure that clinic or hospital administrators
were aware of this study so that they could then encourage
the population to participate. We were allowed to recruit
in local palaces, churches and health centers/hospitals.
Additionally, the research staff was available for recruiting
during special holidays when relatives would return home
for family celebrations. Cultural sensitivity during study
coordination was ensured by a member of the US team
that was born and raised in the Yoruba community.
Genetic analysis identified non-blood relatives in some
families. Some pedigrees had to be updated several times
as additional information became available. While scien-
tists require accurate information about a participant’s
position in a family it is more important for the traditional
Yoruba family where individuals fit within a family than
how they are biologically related. When obtaining family
histories, we found that “adopted” distant relatives were
sometimes identified as children or parents. We also en-
countered situations where friends of the family werereported as members of the family. These situations re-
quired that research staff approached a certain member of
the family with clear questions to obtain accurate informa-
tion before establishing a pedigree. During DNA analysis
we still identified participants who did not fit in the family
structure. The need for confidentiality in these situations
was discussed among researchers and participants were ei-
ther removed from the pedigree or in rare instances the
family was eliminated from analysis. With increasing edu-
cation, the community may become more aware of in-
heritance and biological relationships within a family and
better understand the significance of genetic family stu-
dies. Until then, investigators should be prepared to ad-
dress these factors in their study plan.
Even though remuneration is always a difficult topic for
recruitment in low resource settings, it is still an incentive
for participants who otherwise may not be able to travel
to a recruitment site or miss some work/earning to volun-
teer for a study “without immediate benefit” to them.
Other studies also reported that some participants ex-
pected more payment for their contribution [29], while
others preferred to have free treatment/cure in lieu of
money [44]. Investigators should be aware of the potential
for abuse by opportunists that may impact recruitment.
Our research protocol, for example, required that all study
participants be treated and compensated equally.
In a review of Project SuGar, the author identified
some dynamics that negatively affected recruitment of
African-American families into genetic studies and of-
fered suggestions to enhance recruitment [30]. Im-
pacting factors included economic barriers, core values
including cultural, spiritual and social factors, as well as
health practices of the community. Previous studies have
demonstrated that the majority of Nigerians would par-
ticipate in research activities. Several approaches have
been recommended or used to engage, recruit and retain
Nigerians for genetic studies [45]. Such methods include
the use of community advisory councils, incentives, local
partners/champions, focus groups, awareness through
public forums and less cumbersome wording during the
informed consent process. Our study employed many of
these suggestions.
Knowledge of genetic variations and their roles in dis-
ease pathology and for treatment outcome is significant
in the quest to reduce health disparities. While there
seems to be a recent increase in genetic studies con-
ducted in African countries, the majority is usually in
collaboration with and led by Western scientists. African
countries must continue to be involved and take a lead-
ership role in genetic studies so their people can benefit
from the advances of the genomic and the post-genomic
era. One could argue that the Yoruba people still have to
offer a lot to science. Nigerians have been called upon to
embrace the opportunity of improving their people’s
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genomics [46]. Initiatives such as the MalariaGen [47] and
the Human Heredity and Health in Africa (H3Africa)
project, among others, have begun to address this con-
cern (H3Africa: Human heredity and Health in Africa,
http://www.h3africa.org/).
Conclusions
We believe that our recruitment experience amongst the
Yorubas in Nigeria will be useful to other researchers who
plan similar large genetic study studies in Africa or in
other low resource settings. We have identified adminis-
trative and cultural differences as well as challenges due to
insufficient infrastructure that can lead to delays in suc-
cessful recruitment. As other genetic multigenerational
studies are undertaken in low resource settings, investiga-
tors will recognize that a combination of methods that ad-
dress the issues outlined in this article can enhance the
success of their studies.
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